Your browser doesn't support javascript.
loading
Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity.
Erol, Muhammet Kazim; Coban, Deniz Turgut; Sari, Esin Sogutlu; Bilgin, Ahmet Burak; Dogan, Berna; Ozdemir, Ozdemir; Tunay, Zuhal Ozen.
Afiliación
  • Erol MK; Department of Ophthalmology, Antalya Training and Research Hospital, Antalya, Turkey.
  • Coban DT; Department of Ophthalmology, Antalya Training and Research Hospital, Antalya, Turkey.
  • Sari ES; Department of Ophthalmology, Medical School, Balikesir University, Balikesir, Turkey.
  • Bilgin AB; Department of Ophthalmology, Medical School, Akdeniz University, Antalya, Turkey.
  • Dogan B; Department of Ophthalmology, Antalya Training and Research Hospital, Antalya, Turkey.
  • Ozdemir O; Department of Ophthalmology, Zekai Tahir Burak Hospital, Ankara, Turkey.
  • Tunay ZO; Department of Ophthalmology, Zekai Tahir Burak Hospital, Ankara, Turkey.
Arq Bras Oftalmol ; 78(6): 340-3, 2015.
Article en En | MEDLINE | ID: mdl-26677033
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Retinopatía de la Prematuridad / Inhibidores de la Angiogénesis / Bevacizumab / Ranibizumab Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Infant / Male Idioma: En Revista: Arq Bras Oftalmol Año: 2015 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Brasil
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Retinopatía de la Prematuridad / Inhibidores de la Angiogénesis / Bevacizumab / Ranibizumab Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Infant / Male Idioma: En Revista: Arq Bras Oftalmol Año: 2015 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Brasil